Fluicell® is a biotech company based in Sweden with a focus on single cell biology, pioneering in open-volume microfluidics for the life sciences. As a spin-off from Chalmers University of Technology in Sweden, Fluicell was founded to empower researchers with their tools and capabilities of microfluidics and to allow them to perform the science that they want to achieve.
Their product portfolio includes microfluidic delivery systems such as Biopen Systems and Biozone 6 as well as 3D single-cell bioprinting platforms Biopixlar and Biopixlar AER.
BioPen PRIME and BioPen FLEX systems are easy-to-use microfluidic devices for maintaining local delivery of molecules to single cells, enabling control of the chemical environment around single intact cells in tissue or cell cultures.
Microfluidic single-cell solution delivery